J

Joinn Laboratories China Co Ltd
SSE:603127

Watchlist Manager
Joinn Laboratories China Co Ltd
SSE:603127
Watchlist
Price: 17.68 CNY -6.31% Market Closed
Market Cap: 11.1B CNY
Have any thoughts about
Joinn Laboratories China Co Ltd?
Write Note

Joinn Laboratories China Co Ltd
Pre-Tax Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Joinn Laboratories China Co Ltd
Pre-Tax Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
J
Joinn Laboratories China Co Ltd
SSE:603127
Pre-Tax Income
ÂĄ212.7m
CAGR 3-Years
-22%
CAGR 5-Years
8%
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Pre-Tax Income
ÂĄ10.5B
CAGR 3-Years
31%
CAGR 5-Years
34%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Pre-Tax Income
ÂĄ2.2B
CAGR 3-Years
14%
CAGR 5-Years
37%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Pre-Tax Income
ÂĄ3.7B
CAGR 3-Years
3%
CAGR 5-Years
31%
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Pre-Tax Income
ÂĄ1.3B
CAGR 3-Years
-25%
CAGR 5-Years
8%
CAGR 10-Years
24%
W
WuXi XDC Cayman Inc
HKEX:2268
Pre-Tax Income
ÂĄ359.6m
CAGR 3-Years
123%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Joinn Laboratories China Co Ltd
Glance View

Market Cap
11.1B CNY
Industry
Life Sciences Tools & Services

Joinn Laboratories China Co Ltd is a CN-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Beijing, Beijing and currently employs 2,140 full-time employees. The company went IPO on 2017-08-25. Joinn Laboratories China Co Ltd is a China-based company primarily engaged in the pharmacology and toxicology research of new drugs. Non-clinical research services include drug safety evaluation, pharmacokinetic research as well as pharmacological and pharmacodynamic research. Clinical trials and related services include clinical contract research organization services, phase I clinical research collaboration unit (CRU), and bioanalysis services. Experimental model business mainly includes rodents and non-human primates. The firm conducts its businesses both in the domestic market and overseas markets.

Intrinsic Value
17.6 CNY
Fairly Valued
Intrinsic Value
Price
J

See Also

What is Joinn Laboratories China Co Ltd's Pre-Tax Income?
Pre-Tax Income
212.7m CNY

Based on the financial report for Jun 30, 2024, Joinn Laboratories China Co Ltd's Pre-Tax Income amounts to 212.7m CNY.

What is Joinn Laboratories China Co Ltd's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 5Y
8%

Over the last year, the Pre-Tax Income growth was -77%. The average annual Pre-Tax Income growth rates for Joinn Laboratories China Co Ltd have been -22% over the past three years , 8% over the past five years .

Back to Top